Hjem › Leverkreft (hepatocellulært karcinom) › California › San Francisco
Kliniske studier for Leverkreft (hepatocellulært karcinom) i San Francisco, CA
14 studier for Leverkreft (hepatocellulært karcinom) søker deltakere på steder i og rundt San Francisco (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of ZW251 in Participants With Advanced Solid Tumors
RekruttererFase 1
- UCSF Comprehensive Cancer Center, San Francisco
National Liver Cancer Screening Trial
RekruttererFase 4
- University of California, San Francisco, San Francisco
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RekruttererFase 1
- UCSF Medical Center at Mount Zion, San Francisco
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RekruttererObservasjonsstudie
- Sutter Bay Hospitals, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
RekruttererFase 3
- California Pacific Medical Center-Pacific Campus, San Francisco
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Rekrutterer
- University of California, San Francisco, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
RekruttererFase 1/2
- UCSF Benioff Children's Hospitals, San Francisco
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
RekruttererFase 2
- University of California San Francisco, San Francisco
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
RekruttererFase 2
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, San Francisco
A Multicenter Cancer Biospecimen Collection Study
RekruttererObservasjonsstudie
- Curebase, San Francisco
Leverkreft (hepatocellulært karcinom)-studier i andre byer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Boston, MA18 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
- San Antonio, TX13 studier
Andre studier i San Francisco
- Prostatakreft45 studier
- Brystkreft43 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)35 studier
- Hjertesvikt29 studier
- Metastatisk kreft28 studier
- Lungekreft22 studier
- Melanom22 studier
- Pankreaskreft20 studier
- Eggstokkreft19 studier
- Kolorektal kreft18 studier
- Kardiovaskulær sykdom18 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.